WELL

NYSE·Real Estate·REIT - Healthcare Facilities·USA

Latest market price

252.07

+5.02+2.03%

Overview Short InterestFilings

WELLQT59Welltower Inc.·NYSE

Overview Short InterestFilings

252.07+2.03%

Earnings

Up 2.0% — Earnings due 2026-07-27 — pre-report positioning.

Medium confidence

Loading chart...

Screen all →

VTR+2.67%$100.53 OHI+1.47%$51.72 DOC+0.86%$22.27 AHR+1.88%$57.44 CTRE+2.13%$43.25 HR+1.23%$21.40 SBRA+1.50%$22.36 NHI+0.74%$80.54

Snapshot

Index

S&P 500

P/E

122.96

EPS (ttm)

Analyst Ratings

Date	Action	Analyst	Rating	Target
Jul-22-26	Reiterated	Mizuho Securities	Buy	$239 → $260
Jul-08-26	Reiterated	UBS	Neutral	$249 → $271
Jul-07-26	Initiated	Barclays	Equal Weight	$95 → $254
Jun-16-26	Resumed	Raymond James	Outperform	$82 → $226
May-22-26	Reiterated	Mizuho Securities	Buy	$239
May-21-26	Reiterated	Scotiabank	Sector Outperform	$236 → $248
May-12-26	Reiterated	Jefferies	Buy	$237 → $248
May-04-26	Reiterated	BMO Capital	Outperform	$240 → $245
May-04-26	Reiterated	RBC Capital	Sector Perform	$230 → $238
May-04-26	Reiterated	UBS	Neutral	$240 → $249

Company

Welltower Inc. (NYSE:WELL), an S&P 500 company based in Toledo, Ohio, is a leader in reshaping healthcare infrastructure. This Real Estate Investment Trust (REIT) strategically collaborates with premier operators in seniors housing, post-acute care, and health systems. Their core mission is to finance the vital property assets required to expand innovative care delivery models, thereby enhancing overall public wellness and healthcare experiences. Welltower's portfolio encompasses a variety of properties, including seniors housing, post-acute communities, and outpatient medical facilities, all situated primarily within key, rapidly growing markets across the United States, Canada, and the United Kingdom.

Ownership

Total institutional ownership61.08%

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 12/31/2025	FY 2024 12/31/2024	FY 2023 12/31/2023	FY 2022 12/31/2022	FY 2021 12/31/2021	FY 2020 12/31/2020	FY 2019 12/31/2019	FY 2018 12/31/2018
Total Revenue	11,584	10,667	7,854	6,478	5,776	4,709	4,587	5,100	4,671
Cost of Goods Sold Incl. D&A	7,081	6,488	4,830	3,948	3,559	2,775	2,598	2,690	2,433
Gross Profit	4,502	4,179	3,023	2,530	2,217	1,935	1,989	2,410	2,238
Selling, General and Administrative Excl. Other	1,751	1,748	235	179	150	127	128	127	126
Research and Development	0	0	0	0	0	0	0	0	0
Other Operating Expense	2,217	2,076	1,643	1,411	1,321	1,045	1,133	1,045	951
Operating Income	534	355	1,146	940	746	763	727	1,238	1,161
Interest Expense	700	652	574	608	530	490	514	556	527
Unusual Expense	—	—	—	—	—	—	—	—	—
Non-Operating Income (Expense)	1,631	1,252	404	32	-49	110	836	651	204
Net Income Before Taxes	1,468	955	976	365	168	383	1,049	1,333	838
Income Taxes	10	-7	3	6	7	9	10	3	9
Consolidated Net Income	1,408	937	952	340	141	336	979	1,232	805
Net Income From Continuing Operations	1,457	962	973	358	161	374	1,039	1,330	830
Net Income	1,408	937	952	340	141	336	979	1,232	805
EPS (Recurring)	2.05	1.41	1.58	0.66	0.31	0.79	2.36	3.07	2.03
EPS (Basic, Before Extraordinaries)	2.05	1.41	1.58	0.66	0.31	0.79	2.36	3.07	2.03
EPS (Diluted)	2.01	1.39	1.57	0.66	0.30	0.78	2.33	3.05	2.02
EBITDA	2,638	2,310	2,778	2,401	2,039	1,714	1,533	2,142	1,920
Other After Tax Adjustments	—	—	—	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—	—	—	—
Price To Earnings Ratio	125.41	133.53	80.27	136.62	218.50	109.96	27.73	26.81	34.36
Price To Sales Ratio	15.23	11.59	9.68	7.18	5.24	7.74	5.85	6.45	5.56
Gross Margin	38.86	39.18	38.49	39.06	38.38	41.09	43.36	47.25	47.91
Operating Margin	4.61	3.33	14.59	14.51	12.92	16.20	15.85	24.27	24.86
Net Margin	12.15	8.78	12.12	5.25	2.44	7.14	21.34	24.16	17.23
Shares Outstanding	700	666	603	516	462	425	415	402	374
Market Capitalization	176,449	123,616	75,996	46,528	30,284	36,452	26,817	32,876	25,959
Operating Lease Expense	—	—	—	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Unlock with Premium

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Gundlach Andrew	Director	Jun 30 '25	Buy	151.46	20,000	3,029,200	20,000	Jul 02
Mitra Shankh	CEO	Jun 06 '25	Sale	152.48	86,219	13,146,636	17,258	Jun 11
Chaudhri Nikhil	Co-President and CIO	Jun 06 '25	Sale	152.48	10,527	1,605,229	0	Jun 10
Mcqueen Matthew Grant	Chief Legal Officer	Jun 06 '25	Sale	152.48	8,854	1,350,000	7,565	Jun 10
Burkart John F.	Vice Chairman and COO	Jun 06 '25	Sale	152.48	8,854	1,350,000	1,318	Jun 10
McHugh Timothy	Co-President and CFO	Jun 06 '25	Sale	152.48	13,116	2,000,000	12,884	Jun 10
DeSalvo Karen B	Director	Apr 30 '24	Sale	151.43	4,000	605,720	11,314	May 01
Fieweger Joshua	SVP, Chief Accounting Officer	Feb 18 '25	Option Exercise	74.86	18,496	1,384,518	25,025	Feb 24
BACON KENNETH J	Director	Dec 09 '24	Sale	130.19	2,200	286,418	12,379	Dec 10
BACON KENNETH J	Director	Jun 04 '24	Sale	103.91	1,800	187,038	14,579	Jun 05
Fieweger Joshua	SVP, Chief Accounting Officer	Feb 13 '24	Option Exercise	0.00	13,138	0	17,746	Feb 15


Market Cap	177.94B	Forward P/E	77.62	EPS next Y	3.25	Insider Trans	0.00%	Shs Float	704.94M	Perf Month	13.84%


Enterprise Value	193.22B	PEG	7.17	EPS next Q	-	Inst Own	61.08%	Short Float	2.70%	Perf Quarter	21.05%


Income	1.42B	P/S	15.36	EPS this Y	44.10%	Inst Trans	-	Short Ratio	5.54	Perf Half Y	38.53%


Sales	11.58B	P/B	4.03	EPS next Y	12.12%	ROA	2.09%	Short Interest	19.07M	Perf YTD	35.81%


Book/sh	-	P/C	59.74	EPS next 5Y	21.54%	ROE	3.51%	52W High	252.93 -0.34%	Perf Year	55.95%


Cash/sh	-	P/FCF	70.00	EPS past 3/5Y	66.71% -9.82%	ROIC	0.82%	52W Low	158.24 59.30%	Perf 3Y	213.44%


Dividend Est.	2.96 (1.17%)	EV/EBITDA	73.26	Sales past 3/5Y	22.69% 18.39%	Gross Margin	38.87%	Volatility	2.00% 2.13%	Perf 5Y	181.08%


Dividend TTM	2.96 (1.17%)	EV/Sales	16.68	EPS Y/Y TTM	28.03%	Oper. Margin	4.62%	ATR (14)	5.31	Perf 10Y	230.93%


Dividend Ex-Date	May 13, 2026	Quick Ratio	3.20	Sales Y/Y TTM	47.49%	Profit Margin	12.15%	RSI (14)	74.12	Recom	2.26


Dividend Gr. 3/5Y	4.94% 0.87%	Current Ratio	3.20	EPS Q/Q	-15.00%	SMA20	6.36%	Beta	0.74	Target Price	243.18


Payout	139.68%	Debt/Eq	0.46	Sales Q/Q	38.38%	SMA50	13.77%	Rel Volume	0.96	Prev Close	247.05


Employees	712	LT Debt/Eq	0.49	Earnings	Jul 27	SMA200	24.57%	Avg Volume	3.44M	Price	252.07


IPO Date	Mar 19, 1980	Option/Short	Yes / Yes	EPS/Sales Surpr.	50.18% 7.43%	Net Debt/EBITDA	5.79	Volume	3,306,776	Change	2.03%